Nexalin Technology (NXL) Notes Payables (2021 - 2023)
Nexalin Technology (NXL) posted quarterly Notes Payables of $500000.0 for Q3 2023, little changed year-over-year from $500000.0 in Q3 2022, and little changed quarter-over-quarter from $500000.0 in Q2 2023.
Nexalin Technology (NXL) Notes Payables (2021 - 2023) Analysis & Trends
Nexalin Technology's Notes Payables history runs 3 years deep, the most recent figure standing at $500000.0 for Q3 2023.
- In Q3 2023, Notes Payables changed 0.0% year-over-year to $500000.0; the TTM figure through Sep 2023 stood at $500000.0 (changed 0.0% YoY), while the FY2022 annual figure was $500000.0, changed 0.0% from the prior year.
- Notes Payables for Q3 2023 stood at $500000.0, roughly flat from $500000.0 in the prior quarter.
- The five-year high for Notes Payables was $500000.0 in Q4 2021, with the low at $500000.0 in Q4 2021.
- The 3-year median for Notes Payables is $500000.0 (2021), against an average of $500000.0.
- Peak annual rise in Notes Payables reached 0.0% in 2022, while the deepest fall reached 0.0% in 2022.
- Nexalin Technology's Notes Payables stood at $500000.0 in 2021, then changed by 0.0% to $500000.0 in 2022, then changed by 0.0% to $500000.0 in 2023.
- Business Quant data shows NXL's Notes Payables at $500000.0 in Q3 2023, $500000.0 in Q2 2023, and $500000.0 in Q1 2023.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn |
| 10 | Nexalin Technology | 7.04 Mn | 6.03 Mn | 8,897.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2023 | 500,000.00 |
| Jun 30, 2023 | 500,000.00 |
| Mar 31, 2023 | 500,000.00 |
| Dec 31, 2022 | 500,000.00 |
| Sep 30, 2022 | 500,000.00 |
| Dec 31, 2021 | 500,000.00 |